EcoDrugPlus

Tubulin Beta 6 Class V

Ensembl ID : ENSMMMG00000020221
Gene Symbol: TUBB6
1 Cross references
140 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSMMMG00000020216
Gene Symbol: TUBB
3 Cross references
87 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSMMMG00000019747
Gene Symbol: TP53
3 Cross references
253 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSMMMG00000004445
Gene Symbol: TYR
3 Cross references
266 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSMMMG00000017895
Gene Symbol: TYK2
3 Cross references
196 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSMMMG00000001231
Gene Symbol: TIE1
3 Cross references
203 Possible Orthologues:

Utrophin

Ensembl ID : ENSMMMG00000001257
Gene Symbol: UTRN
3 Cross references
251 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSMMMG00000024565
Gene Symbol: VEGFA
3 Cross references
253 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSMMMG00000022758
Gene Symbol: VDR
3 Cross references
458 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1

Ensembl ID : ENSMMMG00000000568
Gene Symbol: VKORC1
3 Cross references
189 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSMMMG00000018970
Gene Symbol: XDH
3 Cross references
211 Possible Orthologues:

Ensembl ID : ENSMMMG00000022329
Gene Symbol: -
Cross references: -
564 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).